Expert Interview
Discussing Tarsus' XDEMVY (lotilaner ophthalmic solution) for treatment of demodex blepharitis with a current prescriber
Ticker(s): TARSInstitution: The Eye Associates
- Ophthalmologist and retina specialist at The Eye Associates and Medical Director for the Macular Degeneration Association (MDA).
- Diagnosis 300 patients a month with Diabetic Retinopathy.
- Currently manages 400 patients with demodex blepharitis and prescribes XDEMVY.
- Clinical Interest in new treatments for wet macular degeneration, diabetic retinopathy, and uveitis.
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
